Skip to main content
Fig. 4 | Respiratory Research

Fig. 4

From: Trends in initial pharmacological COPD treatment in primary care (2010–2021): a population-based study using the PHARMO Data Network

Fig. 4

Crude proportions of maintenance therapies in Dutch primary care (2010–2021) from the PHARMO data network for females by age group. LABA (long-acting beta-agonist), LAMA (long-acting muscarinic antagonist), LABA-LAMA (combination of LABA and LAMA), LABA-ICS (combination of LABA and inhaled corticosteroids), LABA-LAMA-ICS (combination of LABA, LAMA, and ICS). Shaded areas represent 95% confidence intervals

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us